Login to Your Account



Other News To Note


Friday, April 20, 2012

• Depomed Inc., of Menlo Park, Calif., filed suit earlier this week seeking to prevent Watson Pharmaceuticals Inc., of Parsippany, N.J., from commercializing a generic version of Glumetza (metformin hydrochloride extended-release tablets).

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription